Literature DB >> 28724763

Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Jitendra Kumar1, Viveka Nand Yadav1, Swastik Phulera1, Ashish Kamble1, Avneesh Kumar Gautam1, Hemendra Singh Panwar1, Arvind Sahu2.   

Abstract

Poxviruses display species tropism-variola virus is a human-specific virus, while vaccinia virus causes repeated outbreaks in dairy cattle. Consistent with this, variola virus complement regulator SPICE (smallpox inhibitor of complement enzymes) exhibits selectivity in inhibiting the human alternative complement pathway and vaccinia virus complement regulator VCP (vaccinia virus complement control protein) displays selectivity in inhibiting the bovine alternative complement pathway. In the present study, we examined the species specificity of VCP and SPICE for the classical pathway (CP). We observed that VCP is ∼43-fold superior to SPICE in inhibiting bovine CP. Further, functional assays revealed that increased inhibitory activity of VCP for bovine CP is solely due to its enhanced cofactor activity, with no effect on decay of bovine CP C3-convertase. To probe the structural basis of this specificity, we utilized single- and multi-amino-acid substitution mutants wherein 1 or more of the 11 variant VCP residues were substituted in the SPICE template. Examination of these mutants for their ability to inhibit bovine CP revealed that E108, E120, and E144 are primarily responsible for imparting the specificity and contribute to the enhanced cofactor activity of VCP. Binding and functional assays suggested that these residues interact with bovine factor I but not with bovine C4(H2O) (a moiety conformationally similar to C4b). Mapping of these residues onto the modeled structure of bovine C4b-VCP-bovine factor I supported the mutagenesis data. Taken together, our data help explain why the vaccine strain of vaccinia virus was able to gain a foothold in domesticated animals.IMPORTANCE Vaccinia virus was used for smallpox vaccination. The vaccine-derived virus is now circulating and causing outbreaks in dairy cattle in India and Brazil. However, the reason for this tropism is unknown. It is well recognized that the virus is susceptible to neutralization by the complement classical pathway (CP). Because the virus encodes a soluble complement regulator, VCP, we examined whether this protein displays selectivity in targeting bovine CP. Our data show that it does exhibit selectivity in inhibiting the bovine CP and that this is primarily determined by its amino acids E108, E120, and E144, which interact with bovine serine protease factor I to inactivate bovine C4b-one of the two subunits of CP C3-convertase. Of note, the variola complement regulator SPICE contains positively charged residues at these positions. Thus, these variant residues in VCP help enhance its potency against the bovine CP and thereby the fitness of the virus in cattle.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  adaptive mutations; complement evasion; immune evasion; species tropism; vaccinia virus

Mesh:

Substances:

Year:  2017        PMID: 28724763      PMCID: PMC5599756          DOI: 10.1128/JVI.00668-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Complement and its role in innate and adaptive immune responses.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

2.  Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.

Authors:  A Sahu; S N Isaacs; A M Soulika; J D Lambris
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

4.  Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.

Authors:  Avneesh Kumar Gautam; Yogesh Panse; Payel Ghosh; Malik Johid Reza; Jayati Mullick; Arvind Sahu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

5.  Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment.

Authors:  M Kathryn Liszewski; Paula Bertram; Marilyn K Leung; Richard Hauhart; Lijuan Zhang; John P Atkinson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 6.  Regulation of humoral immunity by complement.

Authors:  Michael C Carroll; David E Isenman
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

7.  The complement component C4 of mammals.

Authors:  A W Dodds; S K Law
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

8.  Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.

Authors:  John Bernet; Jayati Mullick; Yogesh Panse; Pradeep B Parab; Arvind Sahu
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.

Authors:  Ajitanuj Rattan; Shailesh D Pawar; Renuka Nawadkar; Neeraja Kulkarni; Girdhari Lal; Jayati Mullick; Arvind Sahu
Journal:  PLoS Pathog       Date:  2017-03-16       Impact factor: 6.823

10.  Brazilian vaccinia viruses and their origins.

Authors:  Giliane S Trindade; Ginny L Emerson; Darin S Carroll; Erna G Kroon; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  3 in total

1.  Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins.

Authors:  Hina Ojha; Payel Ghosh; Hemendra Singh Panwar; Rajashri Shende; Aishwarya Gondane; Shekhar C Mande; Arvind Sahu
Journal:  Commun Biol       Date:  2019-08-05

2.  Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR.

Authors:  Chorong Park; Chen Peng; M Julhasur Rahman; Sherry L Haller; Loubna Tazi; Greg Brennan; Stefan Rothenburg
Journal:  PLoS Pathog       Date:  2021-01-14       Impact factor: 6.823

Review 3.  Virus-Encoded Complement Regulators: Current Status.

Authors:  Anwesha Sinha; Anup Kumar Singh; Trupti Satish Kadni; Jayati Mullick; Arvind Sahu
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.